Close Menu
    Facebook X (Twitter) Instagram
    GramsaveGramsave
    • Income and Side Hustles
    • Money Psychology and Habits
    • Financial Planning and Goals
    • Credit and Credit Scores
    • Investment and Wealth Building
    Facebook X (Twitter) Instagram
    GramsaveGramsave
    Financial Planning and Goals

    Dow Hits New High Then Falls 466 Points: Stock Market Today

    awais.host01By awais.host01January 7, 2026No Comments4 Mins Read
    dow s&p 500 nasdaq composite on the brink of all-time highs

    dow s&p 500 nasdaq composite on the brink of all-time highs

    (Image credit: Getty Images)

    All three main U.S. equity indexes opened in the green but struggled to hold gains during a mixed trading session on Wednesday. Still, the Dow Jones Industrial Average and the S&P 500 set new all-time intraday highs before slipping into the red, and the Nasdaq Composite is rising on breadth expansion and sector rotation.

    One big name was a big winner and another big name was a big loser, but health care stocks still managed to join communication services and tech stocks in positive territory.

    Consumer discretionary faded late, and energy stocks reflect a market still digesting President Donald Trump’s major move to reestablish U.S. hegemony in the Western Hemisphere through an updated Monroe Doctrine focused on oil reserves purportedly held by Venezuela.

    From just $107.88 $24.99 for Kiplinger Personal Finance

    Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues

    CLICK FOR FREE ISSUE

    Sign up for Kiplinger’s Free Newsletters

    Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more – straight to your e-mail.

    Profit and prosper with the best of expert advice – straight to your e-mail.

    Utility stocks and materials were lower, too, after posting notable gains earlier in the week. Financial stocks retreated, as well, with sector leader JPMorgan Chase (JPM, -2.3%) among the notable names scheduled to report earnings next week.

    The economic calendar is once more a source of timely government-collected data. This week, it’s highlighted by the Friday 8:30 am Eastern Standard Time release of the December jobs report.

    In the interim, the ADP National Employment Report showed private firms added 41,000 jobs last month. And the Job Openings and Labor Turnover Survey (JOLTS) from the Bureau of Labor Statistics indicated job openings, hires and separations were little changed in November.

    “The labor market has cooled a little since the summer,” observes Guy Berger, the workforce economist in residence at Guild, who notes that the unemployment rate has increased and hiring is a little lower than it was a few months ago. “But we don’t have more precision than that,” he adds. “It’d be nice to have more data to prove (or disprove) it. And on Friday, we’re getting that data!”

    By Wednesday’s closing bell, the Dow Jones Industrial Average was off 0.9% to 48,996, despite reaching a fresh peak early in the session. The S&P 500, meanwhile, had shed 0.3% to 6,902, also setting another new all-time intraday high in the process.

    The Nasdaq Composite held on for a 0.2% gain to 23,584, rising for a third straight session even as sectors other than tech continue to show some leadership.

    UNH vs AMGN

    UnitedHealth Group (UNH, -2.1%) was No. 25 among Dow Jones stocks today, even as No. 1 Amgen (AMGN, +3.5%) tried to lead the price-weighted index to the upside.

    The health insurance and care provider joined with other high-priced stocks such as Goldman Sachs (GS, -1.6%) and Caterpillar (CAT, -4.3%), which at $900-plus and $600-plus account for its heaviest weightings, to drag the Dow back into the red after it set new all-time closing highs on Monday and Tuesday. UNH, the No. 7 Dow stock by weighting, closed at $341.81.

    Meanwhile, analyst Mike Yee assumed coverage of AMGN at UBS by raising the firm’s rating on the biotech stock to Buy from Neutral (or Hold) and upping the 12-month target price to $380 from $317.

    In a January 6 note, Yee cites potential earnings upside from Amgen’s MariTide obesity drug and its lipoprotein therapy to address stroke and heart attack risk. The treatments are each in Phase III trials and “both of which should come to market and drive growth to the end of the decade.”

    Is President Trump bad for beer sales?

    Constellation Brands (STZ, -2.1%), facing a particular set of challenging circumstances among consumer staples stocks, is scheduled to report fiscal 2026 third-quarter earnings after Wednesday’s closing bell.

    Jefferies analyst Kaumil Gajrawala downgraded STZ from Buy to Hold and reduced his 12-month target price from $170 to $154 last month, noting that headwinds for Hispanic consumers due to the Trump administration’s immigration policy “appear more prolonged than expected.”

    Results of a recent immigration survey conducted by KFF and The New York Times suggest a delayed recovery, and the analyst lowered his fiscal year 2026 sales and earnings forecast.

    “Immigration policy has led to a notable shift in behavioral patterns,” Gajrawala writes, “with 41% of Hispanic respondents avoiding away-from-home activities.” As Gajrawala explains, Hispanic consumers represent greater than 40% of sales for Constellation’s beer portfolio.

    Related content

    Dow falls High hits Market Points stock Today
    awais.host01
    • Website

    Related Posts

    The Big Four Recession Indicators: December 2025 Employment

    January 9, 2026

    Mortgage Rates Today, Friday, January 9: An Even 6%

    January 9, 2026

    Is Home Insurance Tax Deductible?

    January 9, 2026
    Leave A Reply Cancel Reply

    Recent Posts
    • The Big Four Recession Indicators: December 2025 Employment
    • Mortgage Rates Today, Friday, January 9: An Even 6%
    • Is Home Insurance Tax Deductible?
    • How to Buy Cash-Flowing Rentals in 2026 (Despite High Rates) (Rookie Reply)
    • Cerulli: Plan sponsors eye private markets, but adoption lags
    More About GramSave

    GramSave is a personal finance blog dedicated to helping readers better understand budgeting, saving, money habits, and modern financial tools. We publish simple, practical, and research-based articles designed to support smarter financial choices—no jargon, no pressure, just clear information.

    Most Popular
    • The Big Four Recession Indicators: December 2025 Employment
    • Mortgage Rates Today, Friday, January 9: An Even 6%
    • Is Home Insurance Tax Deductible?
    • How to Buy Cash-Flowing Rentals in 2026 (Despite High Rates) (Rookie Reply)
    • Cerulli: Plan sponsors eye private markets, but adoption lags
    Our Picks
    • The Big Four Recession Indicators: December 2025 Employment
    • Mortgage Rates Today, Friday, January 9: An Even 6%
    • Is Home Insurance Tax Deductible?
    • How to Buy Cash-Flowing Rentals in 2026 (Despite High Rates) (Rookie Reply)
    • Cerulli: Plan sponsors eye private markets, but adoption lags
    Categories
    • Budgeting Basics and Methods
    • Credit and Credit Scores
    • Debt Management and Payoff
    • Financial Planning and Goals
    • Income and Side Hustles
    • Investment and Wealth Building
    • Money Psychology and Habits
    • Saving Money and Emergency Funds
    • Tools and Technology
    Facebook X (Twitter) Instagram Pinterest
    • Home
    • About Us
    • Contact Us
    • Terms and Conditions
    • Privacy Policy
    © 2026 GramSave. Designed by GramSave.

    Type above and press Enter to search. Press Esc to cancel.